DMG Mori AG (0OP0)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 47.10 |
|---|---|
| 52-week range | 45.21 – 47.80 |
| Return, 1 month / 3 months | −1.3% / −0.3% |
| Return, 1 year / 3 years | +3.6% / +17.1% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 4.3% |
| Worst drawdown (1 year) | -2.5% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
DMG Mori is a machine tool maker based in Germany. It builds turning machines, milling machines and machining centres, and supplies automation systems, software and services for them. Its customers are manufacturers in industries such as automotive, aerospace, mechanical engineering and medical technology, who use the equipment to cut and shape metal parts. The company also offers training, maintenance and digital tools that help customers run and monitor their production machinery.
On this site DMG Mori AG appears as a stock on the London Exchange (UK), code 0OP0, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
DMG Mori AG (0OP0) trades on the London Exchange in UK. It last closed at EUR 47.10 on 21 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,508 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.6% and over the last three months it fell 0.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.0% | ||
| From 52-week high | -1.3% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -0.3% | ||
| 6-month return | 0.0% | ||
| 12-month return, skipping the last month | 4.9% | ||
| Stability (higher is calmer) | 98 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 4.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -2.5% | ||
| Liquidity | 5 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 68.3% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | −1.3% |
| 3 months | −0.3% |
| 6 months | −0.0% |
| 1 year | +3.6% |
| 3 years | +17.1% |
| 5 years | +26.1% |
Signals
| 50-day / 200-day average | 47.22 / 47.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 May 2026 | EUR 1.1700 |
| 12 May 2025 | EUR 1.0300 |
| 2 May 2024 | EUR 1.0300 |
| 15 May 2023 | EUR 1.0300 |
| 9 May 2022 | EUR 1.0300 |
| 10 May 2021 | EUR 1.0300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.